About 4D pharma
4D pharma is a Healthcare company based in Manchester (United Kingdom) founded in 2008. Drugs from gut bacteria are developed for multiple diseases. The company has 106 employees. 4D pharma has completed 2 acquisitions, including BIOMAR and GT Biologics. Its focus areas include Life Sciences, Microbiome Therapeutics, Probiotics and Immunology. Its legal entity is 4D PHARMA PLC.
Company details
Founded in 2008 and based in Manchester, United Kingdom, the company operates in the biotechnology sector. Live biotherapeutic products are developed using the MicroRx platform, derived from gut bacteria. These products target diseases such as cancer, gastrointestinal disorders, respiratory conditions, and central nervous system ailments. Operations focus on research and development for therapeutic applications across these areas.
- Headquarters Manchester, United Kingdom
- Employees 106
- SectorsHealthcare
- Website 4dpharmaplc.com
- Social LinkedIn X
- Legal Name 4D Pharma Plc
- Date of Incorporation 10 Jan, 2014
- Jurisdiction LEEDS
- Annual Revenue$685.4 K (USD)153as on Dec 31, 2020
- Net Profit-$33.32 M (USD)-8as on Dec 31, 2020
- Latest Funding Round$24M (USD), Post-IPO
Mar 2021
- Employee Count106
- Investments & AcquisitionsBIOMAR
& 1 more
Funding Insights of 4D pharma
- Total Rounds 7
- Last Round Post-IPO — $24M
- First Round $27.17M
(Feb 2014)
All 7 funding rounds of 4D pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $24M | Post-IPO | – | – | – |
| Jul 2020 | $9.72M | Post-IPO | – | – | – |
| Feb 2020 | $28.65M | Post-IPO | – | – | – |
| Jun 2016 | $27M | Post-IPO | – | – | – |
| Jan 2015 | $52.6M | Post-IPO | – | – | – |
| Jun 2014 | $36.6M | Post-IPO | – | – | – |
| Feb 2014 | $27.17M | Post-IPO | – | – | – |
Investments & Acquisitions by 4D pharma
4D pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include BIOMAR and GT Biologics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Natural products from marine microorganisms are discovered and developed. | biomarmicrobialtechnologies.com | Leon, Spain | 1996 | Apr 2016 | $3.42M | |
Developing naturally occurring human bacteria as biotherapeutics for gastrointestinal diseases. | gt-biologics.com | Shoreview, United States | 2007 | Jun 2014 | $2.04M |
Complete acquisition details for 4D pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of 4D pharma
5 dated milestones of 4D pharma across 13 years, from founding to its latest funding, stage changes and deals.
- Founded 4D pharma is founded.
- Funding First funding round of $27.2M.
- Acquisition Acquires GT Biologics.
- Acquisition Acquires BIOMAR.
- Funding Latest funding round, Post-IPO, of $24.0M.
Web traffic of 4D pharma
Websites that share an audience with 4D pharma (4dpharmaplc.com).
Websites whose visitors overlap most with 4D pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| protexin.com | 100% | 5.4K | #3,389,408 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about 4D pharma
4D pharma was founded in 2008 and raised its 1st funding round 6 years after it was founded.
4D pharma is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
4D pharma has 106 employees.
Annual revenue of 4D pharma is $685.4K as on Dec 31, 2020.
Founded in 2008 and based in Manchester, United Kingdom, the company operates in the biotechnology sector. Live biotherapeutic products are developed using the MicroRx platform, derived from gut bacteria. These products target diseases such as cancer, gastrointestinal disorders, respiratory conditions, and central nervous system ailments. Operations focus on research and development for therapeutic applications across these areas.
4D pharma has made 2 acquisitions, including BIOMAR, and GT Biologics.
4D pharma operates through 4D Pharma Plc.